Liberty Wealth Management LLC Genmab A/S Transaction History

Liberty Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$34.88 - $43.22 $212,942 - $263,858	6,105 New	6,105 $230,000
Q4 2021 Feb 15, 2022	SELL	$35.87 - $47.12 $24,068 - $31,617	-671 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$41.55 - $48.72 $20,650 - $24,213	497 Added 285.63%	671 $28,000
Q2 2021 Aug 13, 2021	SELL	$32.88 - $44.57 $227,858 - $308,870	-6,930 Reduced 97.55%	174 $7,000
Q2 2021 Aug 13, 2021	BUY	$32.88 - $44.57 $233,152 - $316,045	7,091 Added 54546.15%	7,104 $174,000
Q4 2020 Feb 09, 2021	SELL	$33.66 - $40.76 $4,274 - $5,176	-127 Reduced 90.71%	13 $0
Q3 2020 Nov 05, 2020	BUY	$33.07 - $38.68 $4,629 - $5,415	140 New	140 $5,000

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty Wealth Management LLC with notifications on news.